Abstract
The construction of effective and safe theranostics was very important to realize tumor diagnosis and treatment simultaneously. Photothermal therapy had obtained great attention due to its remarkable capability of both cancer treatment and biosecurity. Molybdenum disulfide (MoS2) nanoflakes have shown excellent photothermal conversion efficiency, which were explored to photothermal therapy. However, MoS2 nanoflakes would decrease or quench the intensity of fluorescence when the MoS2 nanoflakes directly incorporated with fluorescence dyes to construct bioimaging theranostic systems. In this work, MoS2 nanoflakes embedded into MSNs to construct photothermal nanomaterials, which realized the nanoparticle size controllable. Fluorescein isothiocyanate (FITC) conjugated with mesoporous silica nanoparticles via amide bonds for bioimaging. It was more stable than physical absorption. As expected, the as-prepared FITC–MoS2 MSNs possessed photothermal effect, fluorescence stability and photostability. FITC–MoS2 MSNs were quickly taken up by HepG2 cells. Meanwhile, the HepG2 cells could be efficiently ablated under the 808 nm near-infrared laser irradiation. These results proved that we successfully constructed multifunctional MSNs for tumor theranostics. It also provided a potentially common nanoplatform for theranostic of biomedical applications.
Graphic abstract
Similar content being viewed by others
References
Slamon DJ et al (2001) Use of chemotherapy plus a monoclonal antibody against Her2 for metastatic breast cancer that overexpresses Her2. N Engl J Med 344:783–792
Morris M, Eifel PJ, Lu JD, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137–1143
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer Treatment and survivorship statistics, 2016. CA-Cancer J Clin 66:271–289
Hanna N et al (2004) Randomized phase iii trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 22:1589–1597
Cobleigh MA et al (1999) Multinational study of the efficacy and safety of humanized Anti-Her2 monoclonal antibody in women who have Her2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 17:2639–2648
Boisselier E, Astruc D (2009) Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 38:1759–1782
Dreaden EC, Alkilany AM, Huang X, Murphy CJ, El-Sayed MA (2012) The golden age: gold nanoparticles for biomedicine. Chem Soc Rev 41:2740–2779
Ayala-Orozco C et al (2014) Au nanomatryoshkas as efficient near-infrared photothermal transducers for cancer treatment: benchmarking against nanoshells. ACS Nano 8:6372–6381
Jain PK, Huang XH, El-Sayed IH, El-Sayed MA (2008) Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res 41:1578–1586
Huang XH, El-Sayed IH, Qian W, El-Sayed MA (2006) Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 128:2115–2120
Huang XH, Neretina S, El-Sayed MA (2009) Gold nanorods: from synthesis and properties to biological and biomedical applications. Adv Mater 21:4880–4910
Robinson JT, Tabakman SM, Liang YY, Wang HL, Casalongue HS, Vinh D, Dai HJ (2011) Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc 133:6825–6831
Lal S, Clare SE, Halas NJ (2008) Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc Chem Res 41:1842–1851
Gobin AM, Lee MH, Halas NJ, James WD, Drezek RA, West JL (2007) Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett 7:1929–1934
Qian X, Shen S, Liu T, Cheng L, Liu Z (2015) Two-dimensional Tis2 nanosheets for in vivo photoacoustic imaging and photothermal cancer therapy. Nanoscale 7:6380–6387
Cheng L, Yuan C, Shen S, Yi X, Gong H, Yang K, Liu Z (2015) Bottom-up synthesis of metal-ion-doped Ws2 nanoflakes for cancer theranostics. ACS Nano 9:11090–11101
Matte H, Gomathi A, Manna AK, Late DJ, Datta R, Pati SK, Rao CNR (2010) MoS2 and Ws2 Analogues of graphene. Angewandte Chemie-International Edition 49:4059–4062
Yin W et al (2014) High-throughput synthesis of single-layer MoS2 nanosheets as a near-infrared photothermal-triggered drug delivery for effective cancer therapy. ACS Nano 8:6922–6933
Liu T, Wang C, Gu X, Gong H, Cheng L, Shi X, Feng L, Sun B, Liu Z (2014) Drug delivery with pegylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer. Adv Mater 26:3433–3440
Chou SS, Kaehr B, Kim J, Foley BM, De M, Hopkins PE, Huang J, Brinker CJ, Dravid VP (2013) Chemically exfoliated MoS2 as near-infrared photothermal agents. Angewandte Chemie-International Edition 52:4160–4164
Wang Y, Ma T, Ma S, Liu Y, Tian Y, Wang R, Jiang Y, Hou D, Wang J (2017) Fluorometric determination of the antibiotic kanamycin by Aptamer-induced fret quenching and recovery between MoS2 nanosheets and carbon dots. Microchim Acta 184:203–210
Wang J, Xu M, Wang K, Chen Z (2019) Stable mesoporous silica nanoparticles incorporated with MoS2 and Aie for targeted fluorescence imaging and photothermal therapy of cancer cells. Colloids Surf B: Biointerfaces 174:324–332
Tang F, Li L, Chen D (2012) Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater 24:1504–1534
Kang N, Paudel HP, Leuenberger MN, Tetard L, Khondaker SI (2014) Photoluminescence quenching in single-layer MoS2 via oxygen plasma treatment. J Phys Chem C 118:21258–21263
Liu T et al (2015) Iron oxide decorated MoS2 nanosheets with double pegylation for chelator-free radio labeling and multimodal imaging guided photothermal therapy. ACS Nano 9:950–960
Trewyn BG, Slowing II, Giri S, Chen H-T, Lin VSY (2007) Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol–gel process and applications in controlled release. Acc Chem Res 40:846–853
Mihai GD, Meynen V, Mertens M, Bilba N, Cool P, Vansant EF (2010) ZnO nanoparticles supported on mesoporous MCM-41 and SBA-15: a comparative physicochemical and photocatalytic study. J Mater Sci 45:5786–5794. https://doi.org/10.1007/s10853-010-4652-8
Xie J, Xiao D, Zhao J, Hu N, Bao Q, Jiang L, Yu L (2016) Mesoporous silica particles as a multifunctional delivery system for pain relief in experimental neuropathy. Adv Healthc Mater 5:1213–1221
Zhai R, Xue XH, Zhang LY, Yang X, Zhao LP, Zhang CH (2019) Strain-specific anti-inflammatory properties of two akkermansia muciniphila strains on chronic colitis in mice. Front Cell Infect Microbiol 9:239
Torney F, Trewyn BG, Lin VSY, Wang K (2007) Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat Nanotechnol 2:295–300
Khurana C, Vala AK, Andhariya N, Pandey OP, Chudasama B (2014) Antibacterial activity of silver: the role of hydrodynamic particle size at nanoscale. J Biomed Mater Res, Part A 102:3361–3368
Qin W, Ding D, Liu JZ, Yuan WZ, Hu Y, Liu B, Tang BZ (2012) Biocompatible nanoparticles with aggregation-induced emission characteristics as far-red/near-infrared fluorescent bioprobes for in vitro and in vivo imaging applications. Adv Func Mater 22:771–779
Bouchoucha M, Cote M-F, C-Gaudreault R, Fortin M-A, Kleitz F (2016) Size-controlled functionalized mesoporous silica nanoparticles for tunable drug release and enhanced anti-tumoral activity. Chem Mater 28:4243–4258
Zhao J, Xie P, Ye C, Wu C, Han W, Huang M, Wang S, Chen H (2018) Outside-in synthesis of mesoporous silica/molybdenum disulfide nanoparticles for antitumor application. Chem Eng J 351:157–168
Wang Y, Wang S, Li C, Qian M, Bu J, Wang J, Huang R (2016) Facile growth of well-dispersed and ultra-small MoS2 nanodots in ordered mesoporous silica nanoparticles. Chem Commun 52:10217–10220
Ge J, Chen P, Jia Q, Liu W, Zhou H, Zhou B, Liu Q, Wang P (2015) A facile high-speed vibration milling method to mass production of water-dispersible silicon quantum dots for long-term cell imaging. Rsc Advances 5:35291–35296
Wang YT, Wang L, Yan MM, Cai AR, Dong SL, Hao JC (2019) Plasmonic microgels of Au nanorods: self-assembly and applications in chemophotothermo-synergistic cancer therapy. J Colloid Interface Sci 536:728–736
Wang S, Chen Y, Li X, Gao W, Zhang L, Liu J, Zheng Y, Chen H, Shi J (2015) Injectable 2d MoS2-integrated drug delivering implant for highly efficient Nir-triggered synergistic tumor hyperthermia. Adv Mater 27:7117–7122
Zhao YN, Trewyn BG, Slowing II, Lin VSY (2009) Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic amp. J Am Chem Soc 131:8398
Wang S, Li X, Chen Y, Cai X, Yao H, Gao W, Zheng Y, An X, Shi J, Chen H (2015) A facile one-pot synthesis of a two-dimensional MoS2/Bi2S3 composite theranostic nanosystem for multi-modality tumor imaging and therapy. Adv Mater 27:2775
Fu C, He F, Tan L, Ren X, Zhang W, Liu T, Wang J, Ren J, Chen X, Meng X (2017) MoS2 nanosheets encapsulated in sodium alginate microcapsules as microwave embolization agents for large orthotopic transplantation tumor therapy. Nanoscale 9:14846–14853
Yao S, Shao A, Zhao W, Zhu S, Shi P, Guo Z, Zhu W, Shi J (2014) Fabrication of mesoporous silica nanoparticles hybridised with fluorescent Aie-active quinoline-malononitrile for drug delivery and bioimaging. RSC Adv 4:58976–58981
Chen L, Feng Y, Zhou X, Zhang Q, Nie W, Wang W, Zhang Y, He C (2017) One-pot synthesis of MoS2 nanoflakes with desirable degradability for photothermal cancer therapy. ACS Appl Mater Interfaces 9:17347–17358
Liu L, Wang J, Tan X, Pang X, You Q, Sun Q, Tan F, Li N (2017) Photosensitizer loaded PEG–MoS2–Au hybrids for Ct/Nirf imaging-guided stepwise photothermal and photodynamic therapy. J Mater Chem B 5:2286–2296. https://doi.org/10.1039/c6tb03352k
Chen L, Zhou X, Nie W, Feng W, Zhang Q, Wang W, Zhang Y, Chen Z, Huang P, He C (2017) Marriage of albumin–gadolinium complexes and MoS2 nanoflakes as cancer theranostics for dual-modality magnetic resonance/photoacoustic imaging and photothermal therapy. ACS Appl Mater Interfaces 9:17786–17798
Cheng W, Wang T, Liang CY, Liu G, Mei L, Zeng XW (2017) Folic acid-targeted polydopamine-based surface modification of mesoporous silica nanoparticles as delivery vehicles for cancer therapy. J Control Release 259:E132–E133
Wang K et al (2016) Aggregation induced emission fluorogens based nanotheranostics for targeted and imaging-guided chemo-photothermal combination therapy. Small 12:6568–6575
Majoros IJ, Myc A, Thomas T, Mehta CB, Baker JR (2006) PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. J Biomacromol 2:572–579
Acknowledgements
This work was supported by the National Natural Science Foundation of China (No. 21675177, 21604048) and the Science and Technology Planning Project of Guangdong Province (No. 2016B030303002) and GDAS' Project of Science and Technology Development (2020GDASYL-20200102008).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declared that they have no conflicts of interest to this work. We declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, J., Li, Z., Yin, Y. et al. Mesoporous silica nanoparticles combined with MoS2 and FITC for fluorescence imaging and photothermal therapy of cancer cells. J Mater Sci 55, 15263–15274 (2020). https://doi.org/10.1007/s10853-020-04950-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10853-020-04950-7